Skip to main content
Account

Peer review reports

From: The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Original Submission
12 Feb 2020 Submitted Original manuscript
6 Apr 2020 Reviewed Reviewer Report - Andrew Hall
22 Apr 2020 Reviewed Reviewer Report - Megan Branda
14 May 2020 Author responded Author comments - Alessio Crippa
Resubmission - Version 2
14 May 2020 Submitted Manuscript version 2
20 May 2020 Reviewed Reviewer Report - Andrew Hall
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
15 Jun 2020 Editorially accepted
26 Jun 2020 Article published 10.1186/s13063-020-04515-8

Learn about peer review

Back to article page

Navigation